Sign in with Twitter

Username:

Roche @Roche Basel, Switzerland

Doing now what patients need next! Read our community guidelines: https://t.co/B1qDGA9Dzu

1,448 Following   214,278 Followers   12,384 Tweets

Joined Twitter 2/13/09


We are proud to announce that our cancer immunotherapy combination has received FDA approval as a new treatment for… https://t.co/JUgmqqZM5E
6/2
2020
At #ASCO20 participants discuss the latest #science to achieve progress for patients under the motto “Unite and Con… https://t.co/6d9XQEvazP
6/1
2020
Wonder what's the "new normal" in #healthcare? Hear Levi Garraway, Chief Medical Officer & Head of Global Product D… https://t.co/81rFzwvI4XWith #ASCO20 underway, make sure to check out the Special Clinical Science Symposium at 10:30am ET today to hear ab… https://t.co/Aaw3Nx4kroDespite many of us working from home, our colleagues around the world are proud to come together to support… https://t.co/soeXL611bF
5/31
2020
Our thanks continues to the community of people working to understand #COVID19 👉 https://t.co/iCvVbijhmihttps://t.co/rjyjgnWaAsASCO20 takes place virtually under unprecedented circumstances. Only through partnerships and working together we c… https://t.co/nUFtR5I8hp“Unite and Conquer; Accelerating Progress Together” – #ASCO20 calls for partnerships to change the course of… https://t.co/BJwAadP4QgToday is #WorldMSDay! We’re #StayingConnected not only to each other, but also the facts as we journey these unprec… https://t.co/IFogKkehQZ
5/30
2020
The speed and scope of the #coronavirus crisis poses extraordinary challenges for leaders. Hear Bill Anderson, Roch… https://t.co/J1ynVxJibsInnovative treatments that continuously deliver medicine to the eye may be able to provide reliable vision improvem… https://t.co/vWLhNpL34RWe are proud to announce the first CHMP positive opinion for a tumour-agnostic medicine for NTRK fusion-positive so… https://t.co/u8RqjIkMCsWhy can we shop and bank from home, but need to see a doctor to check our #health? A team of people from a #startuphttps://t.co/n4eKXdhRUjWe are pleased to announce further results from our pivotal phase III trial in ALK-positive #NSCLC at #ASCO20. Find… https://t.co/MWnfwYJzNqASCO 2020 is a time to reflect on progress in #personalisedhealthcare for #cancer – not just the breakthroughs from… https://t.co/VIusyvPaguWe are committed to tackling the ever increasing burden of cancer to develop transformative solutions for patients,… https://t.co/lj3ihgeT2CDuring these challenging times, working together is more important than ever. Media: visit our #ASCO20 virtual news… https://t.co/vwH2gkh4m2
5/29
2020
Delve into this virtual panel with @pravenenath, Roche Global Head for Digital Health, during #WorldHealthAssemblyhttps://t.co/4LVRZQnDPD"We must come together to pursue the common good." Roche Pharma CEO. Read more about what #science and societal act… https://t.co/1hpeKI0bFk @LamyaRF Hi Lamya, our virtual newsroom is accessible for journalists only. If you’d like to register for the ASCO… https://t.co/peI4x6xqbbWorldwide, around 17 million people are living with neovascular or “wet” age-related #MacularDegeneration. This… https://t.co/4j1ayWVS4TWe are proud to announce that the European Medicines Agency (#EMA) has approved a shorter two-hour infusion time fo… https://t.co/yx9nhOdvn2Read Bill Anderson's, Roche Pharma CEO, views on this moment in time, when the work we’re doing in terms of clinica… https://t.co/vXtMvGDpMc
5/28
2020
Our own @pravenenath, Roche Global Head for #Digital Health Strategy, joined a World Health Assembly virtual panel… https://t.co/CPaMHCFtIfLight on: How an antibody test works! #COVID19 #coronavirus https://t.co/ZIWBXK6SeFNeovascular or “wet” age-related #MacularDegeneration is the leading cause of #VisionLoss among people over the age… https://t.co/bC9bvwTHDkWe are happy to announce positive results from our pivotal phase III study of our refillable eye implant, which cou… https://t.co/1AseBsbWvf
5/27
2020
Hear Bill Anderson, Roche Pharma CEO, reflect on the #COVID19 #pandemic and moments of strength and hope that showc… https://t.co/Be7htiwGz1
5/26
2020
Our Head of Partnering James Sabry joined other industry #leaders for a @BioCentury panel to talk about… https://t.co/eblc4HSZdWWhen our partners on the frontline at hospitals are battling #COVID19 #pandemic, we make sure to deliver an immunit… https://t.co/RyxD3B0pI9
5/25
2020
There remains much to understand about #NMOSD but research points to interleukin-6 (IL-6) as likely playing a key r… https://t.co/P1jWM7d7Ch
5/24
2020
Through collaboration with healthcare providers, the #SECUREIBD database tracks #COVID19 outcomes in people living… https://t.co/mAmruY0avt#NMOSD can be hard to diagnose and is often misdiagnosed as MS. Here, Ana explains how doctors spent 2 years ruling… https://t.co/W9fIhIukz8
5/23
2020
People with #NMOSD experience unpredictable, severe relapses that cause neurological damage and disability. We are… https://t.co/ng08d8pWFf#NMOSD is a rare and debilitating autoimmune disease which can cause blindness, muscle weakness and paralysis. At… https://t.co/PQddSal9AzPreeclampsia affects about 8.5 million women a year globally. Although many women show signs and symptoms of… https://t.co/Ncsv8bjkK0Working in collaboration to accelerate scientific progress and improve outcomes for #cancer patients has never been… https://t.co/TcIkqZNrnEWe are pleased to announce the acquisition of Stratos Genomics, an early-stage sequencing company, to further devel… https://t.co/J5XjgQCRH2We are excited to present new safety data from our phase III studies at #EAN2020 for our investigational medicine f… https://t.co/lSp8pQdViQ
5/22
2020
Tomorrow is #WorldPreeclampsiaday. #Preeclampsia is a severe complication during #pregnancy. Clinicians can use lab… https://t.co/nPaZP3lFrz
5/21
2020
What has the response to #COVID19 taught us? #Health experts from the Europe and Asia-Pacific regions discussed thi… https://t.co/raUh9O3rU5
5/20
2020
The FDA’s approval of our cancer #immunotherapy as a first-line monotherapy for certain people with metastatic… https://t.co/Ic7nBI9k6l#StrongerTogether #RochePartnering https://t.co/3Iyeoafasv[WEBINAR TODAY] Join us for a virtual panel where #globalhealth experts and policymakers discuss how health systems… https://t.co/ACXgdDehwd
Retweeted by RocheWe're pleased that today's FDA approval of our cancer #immunotherapy as a first-line monotherapy may offer certain… https://t.co/zp2avKe8AkJoin us today at 5PM CEST for a virtual panel in conjunction with the #WorldHealthAssembly & @HIMSS, where global h… https://t.co/wfaknDkJjYAn important reminder from @efcca of the impact #IBD can have on work-life and wellbeing, especially during these d… https://t.co/ulEM5hpM9bSome heroes don't wear capes, they wear masks 😷. To assist those at the frontline of the #COVID19 #pandemic, our te… https://t.co/L9qsGxyf1nWe’re pleased to announce that the FDA has approved our cancer #immunotherapy as a first-line monotherapy for certa… https://t.co/gvLUdydw3N
5/19
2020
Join us for a virtual panel tomorrow, May 19th, 5PM CEST in conjunction with the @WHO, where global health experts… https://t.co/wgSRPAawTeMany thanks to Dr. Christoph Franz, Chairman of the Board of @Roche, for sharing his perspectives on the impact of… https://t.co/L3X4hD0vvj
Retweeted by RocheEach year, the @ASCO Congress provides invaluable engagement amongst the #oncology community. Working together is m… https://t.co/vLjiV9S070Some patients have to walk 14km to get their treatment. Thanks to our transport partners, we're able to help move w… https://t.co/yvUYZ2GCuh[WEBINAR TUESDAY] Join us to learn about #digitalhealth's role in mitigating health systems’ vulnerabilities, provi… https://t.co/cdalQoLncL
Retweeted by Roche
5/18
2020
Thanks to our partner China Anti-Cancer Association teaming up with our China colleagues, #cancer patients got acce… https://t.co/lbYHICQnj0
5/17
2020
#Tonight we will once again illuminate the Building one in Basel with a heartfelt message of thanks to all those wh… https://t.co/p73M29nqKQWhat happens when passionate people roll up their sleeves? Those affected by cancer have their FIRST EVER online me… https://t.co/7PGPhwoKVb
5/16
2020
Thank you! #StrongerTogether https://t.co/R9QZzaLQSF#Media - Roche launches digital diagnostics solution that allows clinicians to obtain arterial blood gas values fro… https://t.co/sMtubcQD4Q @JulesGo29 Thank you for getting in touch with us. To ensure that the right team takes care of your request, we wou… https://t.co/GPcy2mxsix“We won't stop making masks ‘til every single medical professional in Tucson has one,” says Alicia, the Roche coord… https://t.co/o0yjXmftfQIn an emergency situation, Roche's new digital solution for blood gas analysis could help healthcare professionals… https://t.co/CdD43UVM5ERoche launches new digital solution designed to simplify blood gas analysis and improve patient care.… https://t.co/MHXFIa549s
5/15
2020
Our goal is to find innovative approaches to help a person's immune system fight cancer. Learn more about our novel… https://t.co/DhpS05jfdNWhen life during #COVID19 feels so surreal, the most simple things can make us happy. We wonder what makes you happ… https://t.co/VIWOy7ZCyvWith some comprehensive strategies at the workplace we can make IBD work! https://t.co/wR0RZQy9WF #makeIBDworkhttps://t.co/u8Z0kPES0R
Retweeted by RocheWe are pleased to share the first clinical data of our novel anti-TIGIT cancer #immunotherapy at #ASCO20. With our… https://t.co/gqli3DfVa3We are pleased to announce today the first clinical data of our novel anti-TIGIT cancer immunotherapy in non-small… https://t.co/8e88iI8fmA
5/14
2020
Who do you miss the most during these challenging times? We asked our colleagues around the world, and we want to h… https://t.co/hrzfBGpPzaThe countdown to #ASCO20 has begun! Our Head of Global Product Strategy #Oncology, Elena Bernedo Arzac, reflects on… https://t.co/lIykTAswm5"Ask, who my neighbor is in this? It isn't just about how we get Roche through it but about how we can do our part… https://t.co/VqQ2wffQ8q
5/13
2020
Together, we are stronger than #COVID19. With nearly 100 000 people across the world, the reach of our Roche family… https://t.co/OP8YjKQYuyAt Roche, we have long believed in the power of collaboration to accelerate scientific progress for the benefit of… https://t.co/WRqD2r3iasRoche hired Aviv Regev to lead its Genentech research unit https://t.co/I2Zu7VpOQP
Retweeted by RocheYesterday Roche and Genentech announced the retirement of Mike Varney Ph.D., and the appointment of Aviv Regev Ph.D… https://t.co/AgnjqubHCc
Retweeted by RocheJoin us for a virtual panel in conjunction with the #WorldHealthAssembly & @Roche, where global health experts & po… https://t.co/cAzBN2nCNV
Retweeted by Roche
5/12
2020
https://t.co/fDYtfgCDNeAccurate testing is essential for containing and controlling the COVID-19 #pandemic. Our graphic helps you understa… https://t.co/QQ7hyLljipWith feelings of both sadness and gratitude, we remember Fritz Gerber. We will never forget his exceptional contrib… https://t.co/8mr7Tu1wHbFor #WorldIBDDay2020, we will be showing support for the European Federation of Crohn's & Ulcerative Colitis Associ… https://t.co/WHB7m1zVcn#Antibody tests can help to detect those already infected with SARS-CoV-2, the virus causing COVID-19. See how this… https://t.co/It0AQEUKpz
5/11
2020
Reliable antibody tests can be a game changer in managing the #COVID19 pandemic. https://t.co/3RG4DTK9Xm
5/10
2020
In our new normal, we may need to created some boundaries around work, downtime, and sleep. Paulo Fontoura, Roche G… https://t.co/YL1JwIXCWt
5/8
2020
OK, seriously, here are two *actual* screenshots, courtesy of the @roche team. https://t.co/BGRN1XpU6X
Retweeted by RocheTomorrow 10:00 CET the first episode of the @FutureProofHlth webinar series will go LIVE. Co-chaired by @DHorganEUhttps://t.co/MWZMnUEbxZAt Roche we have long believed in the power of collaboration to accelerate scientific progress for the benefit of p… https://t.co/OSMZKJ3Rq1 @FishburnSimone @michael_gilman @ArrakisTx @BioCentury It was a pleasure catching up 🙌🏽 and chatting about the #partnership. We enjoyed 😊Exclusive fireside chat with @FishburnSimone reveals how @Roche pharma’s years-long pursuit of @ArrakisTx finally y… https://t.co/fXukjkEJSl
Retweeted by RocheFrom dinner in Basel to Zoom under lockdown: James Sabry and @michael_gilman talk to Editor in Chief… https://t.co/4fFw81LYQz
Retweeted by RocheAfter announcing our new partnership with @ArrakisTx a few weeks ago, we are thrilled to hear James Sabry, Head of… https://t.co/vJ7vfIbgQW
5/7
2020
Together with @CCan_org we explore #digitalhealth applications to provide #cancer care across wider geographies. Mi… https://t.co/rWLxzVN61h#DYK that 25 million people around the world have been diagnosed with #heartfailure? In light of… https://t.co/zOjWpeJiNn
5/6
2020
Where there is light, there is knowledge: SARS-CoV-2 testing with electrochemiluminescence technology sheds light o… https://t.co/ZjhIu3MtWJTelehealth has become a vital lifeline to support health workers and cancer patients during this terrible time. It… https://t.co/lSMQk0VWXK
Retweeted by RocheDespite worldwide unprecedented demand on health systems, #cancercare services must continue to function. Discover… https://t.co/HCSgeJekB5
Retweeted by RocheWhen facing COVID-19 symptoms, which technology can be used to help diagnose an active SARS-CoV-2 infection in people?Last week, we presented new data highlighting how earlier initiation and continuation of treatment can affect the n… https://t.co/lVPuj3hlWwIf I have antibodies, I’m immune, right? As with any new disease, there are many unknowns when it comes to immunity… https://t.co/kUmwu84eqh
5/5
2020
Reliable results with a high level of specificity are critical. “Specificity” describes the ability of a test to co… https://t.co/9Eu78XDBRnReliable diagnostic tests that target both infected and recovered patients are needed to help combat #COVID19. https://t.co/bENUcFWEVx
5/4
2020

0